Pro Share Advisors LLC Vbi Vaccines Inc Transaction History

Pro Share Advisors LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$0.29 - $0.64 $613 - $1,354	-2,116 Reduced 8.53%	22,693 $6,000
Q4 2022 Feb 02, 2023	BUY	$0.38 - $22.5 $1,350 - $79,987	3,555 Added 16.73%	24,809 $9,000
Q3 2022 Nov 04, 2022	SELL	$0.73 - $23.4 $294 - $9,453	-404 Reduced 1.87%	21,254 $15,000
Q2 2022 Aug 01, 2022	SELL	$0.66 - $1.81 $9,028 - $24,760	-13,680 Reduced 38.71%	21,658 $17,000
Q1 2022 May 10, 2022	SELL	$1.27 - $2.47 $7,410 - $14,412	-5,835 Reduced 14.17%	35,338 $59,000
Q4 2021 Feb 08, 2022	BUY	$2.21 - $3.22 $38,257 - $55,741	17,311 Added 72.55%	41,173 $97,000
Q3 2021 Nov 12, 2021	SELL	$2.8 - $3.72 $68,443 - $90,931	-24,444 Reduced 50.6%	23,862 $74,000
Q2 2021 Aug 13, 2021	BUY	$2.61 - $4.17 $394 - $629	151 Added 0.31%	48,306 $162,000
Q1 2021 May 14, 2021	BUY	$2.91 - $4.32 $23,963 - $35,575	8,235 Added 20.63%	48,155 $150,000
Q4 2020 Feb 09, 2021	BUY	$2.15 - $3.5 $40,570 - $66,045	18,870 Added 89.64%	39,920 $110,000
Q3 2020 Nov 13, 2020	SELL	$2.77 - $6.17 $6,337 - $14,116	-2,288 Reduced 9.8%	21,050 $60,000
Q2 2020 Aug 03, 2020	BUY	$0.87 - $3.13 $20,304 - $73,047	23,338 New	23,338 $72,000
Q1 2020 May 15, 2020	SELL	$0.73 - $1.91 $15,157 - $39,659	-20,764 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$0.48 - $1.38 $9,966 - $28,654	20,764 New	20,764 $29,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.